Safety and Performance of an Advanced Hybrid Closed-Loop (AHCL) Algorithm with Ultra-rapid Lispro (URLi) and Lispro

被引：1
|
作者：
Pollom, Robyn K.
Nosek, Leszek
Coester, Hans Veit
Zijlstra, Eric
Ghosh, Aritra
Haidar, Ahmad
Jones, Richard
Leohr, Jennifer
Gleissner, Stephanie E.
Dassau, Eyal
Katz, Michelle
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-105-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
105-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog® in Patients with T2D at Multiple Meal-to-Dose Timing Intervals
    Kapitza, Christoph
    Leohr, Jennifer
    Liu, Rong
    Reddy, Shobha
    Dellva, Mary A.
    Matzopoulos, Mark
    Knadler, Mary P.
    Mei, Teng Loh
    Hardy, Thomas
    Kazda, Christof M.
    DIABETES, 2018, 67
  • [32] Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog® in Patients with T1D at Multiple Meal-to-Dose Timing Intervals
    Plum-Moerschel, Leona
    Leohr, Jennifer
    Liu, Rong
    Reddy, Shobha
    Dellva, Mary A.
    Lim, Shufen
    Mei, Teng Loh
    Knadler, Mary P.
    Hardy, Thomas
    Kazda, Christof M.
    DIABETES, 2018, 67
  • [33] COMPATIBILITY AND SAFETY OF ULTRA RAPID LISPRO (URLI) WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) IN PATIENTS WITH TYPE 1 DIABETES (T1D)
    Bode, B.
    Liu, R.
    Hardy, T.
    Ignaut, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A66 - A67
  • [34] Glycaemic outcomes and the importance of active insulin time in the Pivotal trial of the MiniMed™ Advanced Hybrid Closed-Loop (AHCL) system
    Carlson, A.
    Bode, B.
    Christiansen, M.
    Garg, S.
    Kaiserman, K.
    Kipnes, M.
    Liljenquist, D.
    Philis-Tsimikas, A.
    Pop-Busui, R.
    Reed, J.
    Sherr, J.
    Shulman, D.
    Slover, R.
    Thrasher, J.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S86 - S86
  • [35] Safety and Glycemic Outcomes of Adults with Type 2 Diabetes (T2D) in a MiniMed Advanced Hybrid Closed-Loop (AHCL) System Trial
    Bhargava, Anuj
    Thrasher, James
    Bode, Bruce W.
    Warren, Mark L.
    Bergenstal, Richard M.
    Dempsey, Michael
    Reed, John H.
    Ma, Haoxi
    Keiter, Ashleigh
    Cordero, Toni L.
    McVean, Jennifer
    Shin, John
    Rhinehart, Andrew S.
    Vigersky, Robert A.
    DIABETES, 2024, 73
  • [36] An Advanced Closed-Loop Control to Improve the Performance of Hybrid Stepper Motors
    Le, Kien Minh
    Van Hoang, Hung
    Jeon, Jae Wook
    IEEE TRANSACTIONS ON POWER ELECTRONICS, 2017, 32 (09) : 7244 - 7255
  • [37] Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes
    Royston, Chloe
    Boughton, Charlotte
    Nwokolo, Munachiso
    Lakshman, Rama
    Hartnell, Sara
    Wilinska, Malgorzata E.
    Ware, Julia
    Allen, Janet M.
    Thabit, Hood
    Mader, Julia K.
    Bally, Lia
    Leelarathna, Lalantha
    Evans, Mark L.
    Hovorka, Roman
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
  • [38] GLYCEMIC CONTROL WITH ADVANCED HYBRID CLOSED-LOOP (AHCL) TECHNOLOGY IN A DEVELOPING COUNTRY: RESULTS FROM 219 PATIENTS WITH DIABETES IN INDIA
    Mohan, V.
    Jain, S.
    Jevalikar, G.
    Kulkarni, A.
    Swaminathan, K.
    Arrieta, A.
    Shin, J.
    Vigersky, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A128 - A129
  • [39] Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System
    Yuan, Cheng Yi
    Kong, Yee W.
    Amoore, Tess
    Brown, Katrin
    Grosman, Benyamin
    Jenkins, Alicia
    Jones, Hannah
    Kurtz, Natalie
    Lee, Melissa H.
    MacIsaac, Richard
    Netzer, Emma
    Paldus, Barbora
    Robinson, Lesley
    Roy, Anirban
    Sims, Catriona M.
    Trawley, Steven
    Vogrin, Sara
    O'Neal, David N.
    DIABETES CARE, 2024, 47 (04) : 747 - 755
  • [40] TREATMENT SATISFACTION AND STRESS LEVEL: OUTCOMES AFTER ONE MONTH OF ADVANCED HYBRID CLOSED-LOOP (AHCL) THERAPY IN LATIN AMERICA
    Mena-Salas, F.
    Tapia, N.
    Onetto, M. T.
    Grassi, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A213 - A213
12345